Hospira recalls heparin vials due to contamination with human hair
Hospira, Inc., is recalling one lot of its blood thinner Heparin after confirming that a piece of human hair was found floating in a sealed vial.
DEA introduces new drug take-back program to combat prescription drug abuse
A new Drug Enforcement Administration (DEA) rule aims to combat a growing epidemic of prescription drug addiction and abuse by authorizing pharmacies, hospitals, clinics, and others to serve as drop-off sites for unused prescription medications.
Researchers raise safety concerns about nanoparticles in sunscreens, baby power
Nanoparticles, or the tiny bits of particles produced when a mineral is broken down into smaller and smaller bits, have been present for years in consumer products from baby powder to sunscreens, however they may ultimately do more harm than
Study links commonly prescribed anti-anxiety, insomnia drugs to Alzheimer’s in elderly
Older people who used drugs known as benzodiazepines to relieve anxiety and help them sleep are more likely to develop Alzheimer’s disease, and those who use the drugs frequently and in higher doses are at even greater risk, a new
Judge orders mediation to resolve Fosamax lawsuits claiming femur fractures
A New Jersey federal judge told Merck & Co. that it is time to settle with plaintiffs in multidistrict litigation over femur fractures allegedly caused by its osteoporosis drug Fosamax. About 900 cases are still pending in the litigation, which
Federal jury hits Ethicon transvaginal mesh with $3.27 million verdict
Jo Huskey had no idea the turn her life would take after having a 30-minute procedure to implant Ethicon’s transvaginal mesh device in her body to correct urinary incontinence. Plaintiffs attorneys and their witnesses painted a picture for jurors of
Long-term pancreatic cancer risks with class of type 2 diabetes drugs still unknown
Drugs in a class of Type 2 diabetes medications known as DPP-4 inhibitors may not increase the short-term risk of pancreatic cancer, but the long-term risks are still unknown, according to a new study published in the journal Diabetes, Obesity
FDA approves new type of cancer drug to treat advanced melanoma
A new type of cancer drug has been approved by the Food and Drug Administration (FDA) to treat advanced or inoperable melanoma that no longer responds to other drugs.